Long-Term Outcomes and Predictors After Percutaneous Balloon Pulmonary Valvuloplasty for Pediatric Isolated Valvular Pulmonary Stenosis: A Systematic Review - Takeaways - MDSpire

Long-Term Outcomes and Predictors After Percutaneous Balloon Pulmonary Valvuloplasty for Pediatric Isolated Valvular Pulmonary Stenosis: A Systematic Review

  • By

  • Mariana M. Pereira

  • Joana O. Miranda

  • July 9, 2026

  • 0 min

Share

  • 1

    Isolated pulmonary valve stenosis accounts for 7.5% to 10% of congenital heart diseases and is the third most common congenital cardiac anomaly.

  • 2

    Percutaneous balloon pulmonary valvuloplasty (BPV) became the preferred treatment for isolated pulmonary stenosis after its introduction in 1982.

  • 3

    Long-term outcomes of BPV remain unclear, with studies indicating pulmonary valve restenosis and pulmonary insufficiency as common late complications.

  • 4

    The systematic review aimed to provide consistent data on long-term BPV outcomes and identify risk factors for adverse outcomes.

  • 5

    Eligibility criteria for included studies required a pediatric population, isolated pulmonary valve stenosis, BPV treatment, and a follow-up of at least 5 years.

Original Source(s)

Long-Term Outcomes and Predictors After Percutaneous Balloon Pulmonary Valvuloplasty for Pediatric Isolated Valvular Pulmonary Stenosis: A Systematic Review

  • by Mariana M. Pereira, Joana O. Miranda

  • July 9, 2026

Related Content

A predictive model for long-term coronary artery lesion risk in Kawasaki disease

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

Case Report: The effect of early initiation of eteplirsen treatment on the cardiac and motor disease course in an individual with Duchenne muscular dystrophy